Goodbody Health Limited
GDBYF
$0.00
$0.000.00%
OTC PK
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Revenue | 46.96% | 213.00% | 607.17% | 806.59% | 568.61% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 46.96% | 213.00% | 607.17% | 806.59% | 568.61% |
| Cost of Revenue | 62.00% | 237.62% | 633.21% | 889.01% | 576.73% |
| Gross Profit | 34.11% | 192.28% | 584.68% | 742.67% | 561.72% |
| SG&A Expenses | 18.20% | 57.13% | 76.63% | 69.76% | 56.34% |
| Depreciation & Amortization | -37.02% | -5.86% | 54.40% | 135.49% | 160.76% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 30.29% | 103.68% | 174.12% | 176.84% | 127.75% |
| Operating Income | 37.10% | 80.35% | 96.79% | 76.58% | 37.88% |
| Income Before Tax | -22.42% | 36.89% | 71.24% | 50.03% | 36.52% |
| Income Tax Expenses | -- | 173.05% | 220.81% | 155.17% | 100.00% |
| Earnings from Continuing Operations | -25.04% | 33.07% | 67.30% | 47.12% | 34.70% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -25.04% | 33.07% | 67.30% | 47.12% | 34.70% |
| EBIT | 37.10% | 80.35% | 96.79% | 76.58% | 37.88% |
| EBITDA | 31.74% | 96.65% | 116.19% | 97.88% | 54.52% |
| EPS Basic | -4.89% | 57.14% | 84.16% | 79.08% | 68.74% |
| Normalized Basic EPS | 26.37% | 76.18% | 95.27% | 87.39% | 68.85% |
| EPS Diluted | -4.89% | 57.14% | 84.16% | 79.08% | 68.74% |
| Normalized Diluted EPS | 26.37% | 76.18% | 95.27% | 87.39% | 68.85% |
| Average Basic Shares Outstanding | 10.29% | 34.58% | 71.71% | 123.42% | -77.97% |
| Average Diluted Shares Outstanding | 10.29% | 34.58% | 71.71% | 123.42% | -77.97% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |